Wealthspire Advisors (New York)’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
2,435
-282
-10% -$29.2K ﹤0.01% 1081
2026
Q1
$263K Buy
+2,717
New +$279K ﹤0.01% 766
2025
Q4
– Sell
-353
Closed -$44.8K – 1555
2025
Q3
$44.8K Buy
+353
New +$42K ﹤0.01% 1289

Other funds holding EHC

Wealthspire Advisors (New York)'s EHC Position: Q2 2026 in Review

Wealthspire Advisors (New York) reduced its Encompass Health (EHC) stake by 10% in Q2 2026, selling an estimated $29.2K and leaving 2,435 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

Wealthspire Advisors (New York) first reported a position in EHC in Q3 2025 and has held it in 3 quarters since. The position peaked at $263K in Q1 2026. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Wealthspire Advisors (New York) held 2,435 shares of Encompass Health worth $246K as of Q2 2026.
  • Wealthspire Advisors (New York) sold 282 Encompass Health shares in Q2 2026, an estimated $29.2K.
  • Encompass Health made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #1081 holding.
  • Wealthspire Advisors (New York) first reported a position in Encompass Health in Q3 2025 and has held it in 3 quarters since.
  • Wealthspire Advisors (New York)'s Encompass Health position peaked at $263K in Q1 2026.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.